ImmunoBiotics, Inc. (IMBI) is a publicly traded company in the Unknown sector. Across all available filings, 15 corporate insiders have executed 61 transactions totaling $9.2M, demonstrating a bullish sentiment with $9.1M in net insider flow. The most recent transaction on Jan 30, 2023 involved a transaction of 181,902 shares valued at $0.
No significant insider buying has been recorded for IMBI in the recent period.
No significant insider selling has been recorded for IMBI in the recent period.
Based on recent SEC filings, insider sentiment for IMBI is bullish with an Insider Alignment Score of 99/100 and a net flow of $9.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at ImmunoBiotics, Inc. (IMBI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 15 insiders are actively trading IMBI stock, having executed 61 transactions in the past 90 days. The most active insider is Eyal Lalo (Executive), who has made 8 transactions totaling $11.3M.
Get notified when executives and directors at IMBI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Jan 30, 2023 | Peterman Tim | Executive | Award | 181,902 | $N/A | $0 | |
| Jun 14, 2022 | Reitkopf Aaron | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | C. Porter Darryl | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | Lalo Eyal | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | M. Krueger Jill | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | C. Hobbs Landel | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | Friedman Michael | Executive | Award | 67,241 | $N/A | $0 | |
| Jun 14, 2022 | Letizio Lisa | Executive | Award | 67,241 | $N/A | $0 | |
| May 11, 2022 | C. Hobbs Landel | Executive | Purchase | 16,286 | $3.07 | $50.0K | |
| May 11, 2022 | Peterman Tim | Executive | Purchase | 32,573 | $3.07 | $100.0K | |
| May 11, 2022 | Friedman Michael | Executive | Purchase | 195,440 | $3.07 | $600.0K | Large |
| May 11, 2022 | Lalo Eyal | Executive | Purchase | 390,880 | $3.07 | $1.2M | Large |
| May 11, 2022 | Peterman Tim | Executive | Award | 32,573 | $3.07 | $100.0K | |
| May 11, 2022 | Lalo Eyal | Executive | Award | 390,880 | $3.07 | $1.2M | Large |
| May 11, 2022 | Friedman Michael | Executive | Award | 195,440 | $3.07 | $600.0K | Large |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 44 | $12.4M | 57.3% |
Purchase(P) | 11 | $9.2M | 42.2% |
Payment(F) | 1 | $58.5K | 0.3% |
Sale(S) | 2 | $50.3K | 0.2% |
Exercise (Options)(X) | 2 | $0 | 0.0% |
Exercise(M) | 1 | $0 | 0.0% |
Insiders at ImmunoBiotics, Inc. are accumulating shares at an accelerated pace. With 15 insiders making 61 transactions totaling $9.2M in purchases versus $50.3K in sales, the net buying activity of $9.1M signals strong executive confidence. Eyal Lalo (Executive) leads the buying activity with $11.3M in transactions across all time.